{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:52:55Z","timestamp":1765295575917,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1245\/s10434-025-17808-6","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T19:52:29Z","timestamp":1756151549000},"page":"10335-10346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing the Influence of Bladder Cancer on Upper Tract Urothelial Carcinoma Prognoses Following Radical Nephroureterectomy: A Retrospective, Propensity Score-Based Multicenter Cohort Study"],"prefix":"10.1245","volume":"32","author":[{"given":"Shicong","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Seery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"1","key":"17808_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","volume":"84","author":"M Roupr\u00eat","year":"2023","unstructured":"Roupr\u00eat M, Seisen T, Birtle AJ, et al. European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2023 update. Eur Urol. 2023;84(1):49\u201364. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.013.","journal-title":"Eur Urol."},{"key":"17808_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235558","author":"F Lefort","year":"2023","unstructured":"Lefort F, Rhanine Y, Larroquette M, et al. Clinical and biological differences between upper tract carcinoma and bladder urothelial cancer, including implications for clinical practice. Cancers. 2023. https:\/\/doi.org\/10.3390\/cancers15235558.","journal-title":"Cancers"},{"issue":"4","key":"17808_CR3","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","volume":"189","author":"DA Green","year":"2013","unstructured":"Green DA, Rink M, Xylinas E, et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins. J Urol. 2013;189(4):1214\u201321. https:\/\/doi.org\/10.1016\/j.juro.2012.05.079.","journal-title":"J Urol."},{"issue":"4","key":"17808_CR4","first-page":"2233","volume":"12","author":"BW Kim","year":"2015","unstructured":"Kim BW, Ha YS, Lee JN, et al. Effects of previous or synchronous non-muscle invasive bladder cancer on clinical results after radical nephroureterectomy for upper tract urothelial carcinoma: a multi-institutional study. Urol J. 2015;12(4):2233\u20139.","journal-title":"Urol J."},{"issue":"6","key":"17808_CR5","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/ju.0000000000000422","volume":"202","author":"K Kuroiwa","year":"2019","unstructured":"Kuroiwa K, Inokuchi J, Nishiyama H, et al. Impact of previous, simultaneous or subsequent bladder cancer on prognosis after radical nephroureterectomy for upper urinary tract urothelial carcinoma. J Urol. 2019;202(6):1127\u201335. https:\/\/doi.org\/10.1097\/ju.0000000000000422.","journal-title":"J Urol."},{"issue":"8","key":"17808_CR6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.urolonc.2012.03.004","volume":"31","author":"B Milojevic","year":"2013","unstructured":"Milojevic B, Djokic M, Sipetic-Grujicic S, et al. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31(8):1615\u201320. https:\/\/doi.org\/10.1016\/j.urolonc.2012.03.004.","journal-title":"Urol Oncol."},{"issue":"1","key":"17808_CR7","doi-asserted-by":"publisher","first-page":"23.e1","DOI":"10.1016\/j.urolonc.2012.08.010","volume":"32","author":"G Pignot","year":"2014","unstructured":"Pignot G, Colin P, Zerbib M, et al. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2014;32(1):23.e1-8. https:\/\/doi.org\/10.1016\/j.urolonc.2012.08.010.","journal-title":"Urol Oncol."},{"issue":"1","key":"17808_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62(1):100\u201314. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.030.","journal-title":"Eur Urol."},{"issue":"3","key":"17808_CR9","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.eururo.2013.09.003","volume":"65","author":"E Xylinas","year":"2014","unstructured":"Xylinas E, Kluth L, Passoni N, et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014;65(3):650\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2013.09.003.","journal-title":"Eur Urol."},{"issue":"9","key":"17808_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1464-410X.2010.09341.x","volume":"106","author":"P Enrique","year":"2010","unstructured":"Enrique P, Guillermo F, Xavi R, Antoni V, Mariano O, Pedro P. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int. 2010;106(9):1319\u201323. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09341.x.","journal-title":"BJU Int."},{"issue":"1","key":"17808_CR11","doi-asserted-by":"publisher","first-page":"23.e1","DOI":"10.1016\/j.urolonc.2012.08.010","volume":"32","author":"G Pignot","year":"2014","unstructured":"Pignot G, Colin P, Zerbib M, et al. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol. 2014;32(1):23.e1-23.e8. https:\/\/doi.org\/10.1016\/j.urolonc.2012.08.010.","journal-title":"Urol Oncol."},{"issue":"8","key":"17808_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.urolonc.2012.03.004","volume":"31","author":"B Milojevic","year":"2013","unstructured":"Milojevic B, Djokic M, Sipetic-Grujicic S, et al. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. Urol Oncol. 2013;31(8):1615\u201320. https:\/\/doi.org\/10.1016\/j.urolonc.2012.03.004.","journal-title":"Urol Oncol."},{"issue":"12","key":"17808_CR13","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.21037\/tau-21-758","volume":"10","author":"S Zeng","year":"2021","unstructured":"Zeng S, Ying Y, Yu X, Wang L, Zhang Z, Xu C. Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study. Transl Androl Urol. 2021;10(12):4365\u201375. https:\/\/doi.org\/10.21037\/tau-21-758.","journal-title":"Transl Androl Urol."},{"key":"17808_CR14","doi-asserted-by":"publisher","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","volume":"96","author":"G Mathew","year":"2021","unstructured":"Mathew G, Agha R, Albrecht J, et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg. 2021;96:106165. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106165.","journal-title":"Int J Surg"},{"issue":"6","key":"17808_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/ju.0000000000000422","volume":"202","author":"K Kuroiwa","year":"2019","unstructured":"Kuroiwa K, Inokuchi J, Nishiyama H, et al. Impact of previous, simultaneous or subsequent bladder cancer on prognosis after radical nephroureterectomy for upper urinary tract urothelial carcinoma. J Urol. 2019;202(6):1127\u201335. https:\/\/doi.org\/10.1097\/ju.0000000000000422.","journal-title":"J Urol."},{"issue":"4","key":"17808_CR16","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O'Brien","year":"2011","unstructured":"O\u2019Brien T, Ray E, Singh R, Coker B, Beard R. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol. 2011;60(4):703\u201310. https:\/\/doi.org\/10.1016\/j.eururo.2011.05.064.","journal-title":"Eur Urol."},{"issue":"11","key":"17808_CR17","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/jco.2012.45.2128","volume":"31","author":"A Ito","year":"2013","unstructured":"Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 2013;31(11):1422\u20137. https:\/\/doi.org\/10.1200\/jco.2012.45.2128.","journal-title":"J Clin Oncol."},{"issue":"9","key":"17808_CR18","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1442-2042.2008.02114.x","volume":"15","author":"N Soga","year":"2008","unstructured":"Soga N, Arima K, Sugimura Y. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Int J Urol. 2008;15(9):800\u20133. https:\/\/doi.org\/10.1111\/j.1442-2042.2008.02114.x.","journal-title":"Int J Urol."},{"issue":"18","key":"17808_CR19","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-05-0891","volume":"11","author":"TD Jones","year":"2005","unstructured":"Jones TD, Wang M, Eble JN, et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res. 2005;11(18):6512\u20139.","journal-title":"Clin Cancer Res."},{"issue":"6512","key":"17808_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1126\/science.aba7300","volume":"370","author":"R Li","year":"2020","unstructured":"Li R, Du Y, Chen Z, et al. Macroscopic somatic clonal expansion in morphologically normal human urothelium. Science. 2020;370(6512):82\u20139. https:\/\/doi.org\/10.1126\/science.aba7300.","journal-title":"Science."},{"issue":"5","key":"17808_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.eururo.2016.09.046","volume":"71","author":"Y Du","year":"2017","unstructured":"Du Y, Li R, Chen Z, Wang X, Xu T, Bai F. Mutagenic factors and complex clonal relationship of multifocal urothelial cell carcinoma. Eur Urol. 2017;71(5):841\u20133. https:\/\/doi.org\/10.1016\/j.eururo.2016.09.046.","journal-title":"Eur Urol."},{"issue":"8879","key":"17808_CR22","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/0140-6736(93)92066-3","volume":"342","author":"T Habuchi","year":"1993","unstructured":"Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet. 1993;342(8879):1087\u20138.","journal-title":"Lancet."},{"issue":"1","key":"17808_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0022-5347(17)43040-0","volume":"138","author":"WA See","year":"1987","unstructured":"See WA, Chapman PH. Heparin prevention of tumor cell adherence and implantation on injured urothelial surfaces. J Urol. 1987;138(1):182\u20136.","journal-title":"J Urol."},{"issue":"19","key":"17808_CR24","first-page":"5414","volume":"49","author":"WA See","year":"1989","unstructured":"See WA, Miller JS, Williams RD. Pathophysiology of transitional tumor cell adherence to sites of urothelial injury in rats: mechanisms mediating intravesical recurrence due to implantation. Cancer Res. 1989;49(19):5414\u20138.","journal-title":"Cancer Res."},{"issue":"6","key":"17808_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.urolonc.2020.01.008","volume":"38","author":"T van Doeveren","year":"2020","unstructured":"van Doeveren T, van de Werken HJG, van Riet J, et al. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review. Urol Oncol Semin Orig Investig. 2020;38(6):590\u20138. https:\/\/doi.org\/10.1016\/j.urolonc.2020.01.008.","journal-title":"Urol Oncol Semin Orig Investig."},{"issue":"8","key":"17808_CR26","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/bju.12116","volume":"111","author":"S Hurel","year":"2013","unstructured":"Hurel S, Roupr\u00eat M, Ouzzane A, et al. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2013;111(8):1199\u2013207. https:\/\/doi.org\/10.1111\/bju.12116.","journal-title":"BJU Int."},{"issue":"6","key":"17808_CR27","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1464-410X.2011.10893.x","volume":"110","author":"MS Godfrey","year":"2012","unstructured":"Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion. BJU Int. 2012;110(6):798\u2013803. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10893.x.","journal-title":"BJU Int."},{"issue":"5","key":"17808_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bju.16258","volume":"133","author":"GO Cirulli","year":"2024","unstructured":"Cirulli GO, Corsi N, Rakic I, et al. Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis. BJU Int. 2024;133(5):555\u201363. https:\/\/doi.org\/10.1111\/bju.16258.","journal-title":"BJU Int."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17808-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:18:46Z","timestamp":1762352326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17808-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":28,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["17808"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17808-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This was a retrospective study and clinical data were de-identified before analysis, therefore ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}